20 ILCS 745

in effect

20 ILCS 745/1-1

(20 ILCS 745/1-1) (Section scheduled to be repealed on January 1, 2027) Sec. 1-1. Short title. This Act may be cited as the Industrial Biotech Partnership Act. (Source: P.A. 102-991, eff. 1-1-23.)

(20 ILCS 745/1-5) (Section scheduled to be repealed on January 1, 2027) Sec. 1-5. Purpose. Illinois will actively pursue expansion of the industrial biotechnology and biorenewables industry. This growing field closely aligns with several key industries that the State is pursuing through the 2019 "Plan to Revitalize the Illinois Economy and Build the Workforce of the Future", such as agriculture, agriculture technology, life sciences, healthcare, and manufacturing. Illinois is well positioned to lead the nation with ample feedstocks, dedicated research facilities, specialized job training programs, and an existing manufacturing base required to lead this industry. Modifications to several existing programs will ensure the State provides the correct aid and incentives to help attract this growing industry. (Source: P.A. 102-991, eff. 1-1-23.)

20 ILCS 745/1-10 Definitions

(20 ILCS 745/1-10) (Section scheduled to be repealed on January 1, 2027) Sec. 1-10. Definitions. As used in this Act: "Department" means the Department of Commerce and Economic Opportunity. "Industrial biotechnology" means biotechnology focused on new industrial products, such as industrial materials, chemicals and solvents, and feed and food, and new industrial processes. "Industrial biotechnology" does not include health biotechnology (pharmaceuticals), agricultural biotechnology (transgenic crops), or environmental biotechnology (bioremediation). "Partnership" means the Industrial Biotechnology Public-Private Partnership established under this Act. (Source: P.A. 102-991, eff. 1-1-23.)

20 ILCS 745/1-15 Industrial Biotechnology Public-Private Partnership

(20 ILCS 745/1-15) (Section scheduled to be repealed on January 1, 2027) Sec. 1-15. Industrial Biotechnology Public-Private Partnership. (a) There is hereby established the Industrial Biotechnology Public-Private Partnership as a State-sponsored board consisting of members from State agencies, research facilities, industry, and agriculture, to promote and market Illinois as the leading destination for research, development, and commercialization for industrial biotechnology. (b) The Partnership shall consist of the following members: (1) a representative of the Department of Agriculture, appointed by the Director of Agriculture; (2) a representative of the Department of Commerce and Economic Opportunity, appointed by the Director of Commerce and Economic Opportunity; (3) a representative of the Department of Labor, appointed by the Director of Labor; (4) a representative of the National Corn to Ethanol Research Center, appointed by the Director of Commerce and Economic Opportunity; (5) a representative of the Integrated Bioprocessing Research Laboratory, appointed by the Director of Commerce and Economic Opportunity; (6) a representative of the National Center for Agricultural Utilization Research, who shall participate in a non-voting capacity, appointed by the Director of Commerce and Economic Opportunity in consultation with the Director of the Agricultural Research Service of the United States Department of Agriculture; (7) a representative of an additional State-sponsored, university-affiliated laboratory or research institution conducting industrial biotechnology research, other than the entities described in paragraphs (4) and (5), appointed by the Director of Commerce and Economic Opportunity; (8) a representative of an Illinois agricultural commodity group or farmer organization, appointed by the Director of Commerce and Economic Opportunity; (9) a representative of a grain or oilseed processing company with current facilities located in Illinois, appointed by the Director of Commerce and Economic Opportunity; (10) a representative of a biotechnology company, appointed by the Director of Commerce and Economic Opportunity; (11) a representative of an environmental group committed to biorenewables, appointed by the Director of Commerce and Economic Opportunity; and (12) a representative of a union of operating engineers, appointed by the Director of Commerce and Economic Opportunity. (c) Members of the Partnership shall be appointed within 90 days after the effective date of this Act. The Partnership may meet quarterly and may hold its first meeting within 90 days after the appointment of all members. At the first meeting of the Partnership, a Chairperson shall be chosen from among the members. Members of the Partnership shall serve without compensation, but may be reimbursed for any expenses incurred in performing their duties. (d) The Department, or a non-profit organization designated by the Department, shall provide administrative and other support to the Partnership. (Source: P.A. 102-991, eff. 1-1-23.)

20 ILCS 745/1-20 Duties

(20 ILCS 745/1-20) (Section scheduled to be repealed on January 1, 2027) Sec. 1-20. Duties. The Partnership shall have the following duties: (1) Subject to appropriation and matching private funds as provided in Section 1-25, the Partnership shall develop and direct efforts to attract companies to use existing Illinois facilities for research, development, and pre-commercialization activities. Those efforts may include, without limitation: (i) representing Illinois at biotechnology conferences; (ii) developing promotional and marketing materials in coordination with existing research facilities to encourage the use of Illinois facilities; and (iii) facilitating meetings for companies that are prospective candidates for establishing a presence in this State. (2) Subject to appropriation and matching private funds as provided in Section 1-25, the Partnership may develop programs to encourage emerging research, development, and commercializing biotechnology companies to locate production facilities in Illinois, including, but not limited to: (i) acting as an information clearinghouse for new companies on all State programs and investment incentives; and (ii) working with local and regional economic development groups. (3) The Partnership may provide advice and recommendations to State agencies on the administration of grant programs directed at industrial biotechnology. (4) On or before January 31 of the next calendar year to occur after the last day of any State fiscal year in which the Partnership receives State funding, the Partnership shall submit a report to the Department describing the use of appropriated funds by the Partnership in the State fiscal year for which the funds were allocated. The report shall include, but not be limited to, marketing materials produced by the Partnership, meetings attended by members of the Partnership related to Partnership business, and the hosting of companies visiting this State. (Source: P.A. 102-991, eff. 1-1-23.)

20 ILCS 745/1-25 Funding

(20 ILCS 745/1-25) (Section scheduled to be repealed on January 1, 2027) Sec. 1-25. Funding. The Partnership may receive funding through specific appropriations available for its purposes made to the Department. Moneys appropriated to the Department for the use of the Partnership as provided in this Act shall not be disbursed to the Partnership until the Partnership certifies to the Department that it has received at least $3 in private matching funds for every $1 so disbursed. (Source: P.A. 102-991, eff. 1-1-23.)

20 ILCS 745/1-30 Reports

(20 ILCS 745/1-30) (Section scheduled to be repealed on January 1, 2027) Sec. 1-30. Reports. On or before January 31 of the next calendar year to occur after the last day of any State fiscal year in which the Partnership receives State funding, the Department shall submit to the General Assembly and the Governor a report describing the use of appropriated funds by the Partnership in the State fiscal year for which the funds were allocated. (Source: P.A. 102-991, eff. 1-1-23.)

20 ILCS 745/1-35 Rules

(20 ILCS 745/1-35) (Section scheduled to be repealed on January 1, 2027) Sec. 1-35. Rules. The Department shall adopt all rules necessary for the implementation of this Act. (Source: P.A. 102-991, eff. 1-1-23.)

20 ILCS 745/1-40

(20 ILCS 745/1-40) (Section scheduled to be repealed on January 1, 2027) Sec. 1-40. Partnership dissolved. The Partnership is dissolved on December 31, 2025. (Source: P.A. 102-991, eff. 1-1-23.)

20 ILCS 745/1-45 Repeal

(20 ILCS 745/1-45) (Section scheduled to be repealed on January 1, 2027) Sec. 1-45. Repeal. This Act is repealed on January 1, 2027. (Source: P.A. 102-991, eff. 1-1-23.)

Source: Open US Law by Vaquill AI (CC BY 4.0)URL: https://www.ilga.gov/legislation/ilcs/ilcs.aspFetched: 10/17/2026